MycoTOX Profile (Mold Exposure) Mosaic Diagnostics

MycoTOX Profile (Mold Exposure) Mosaic Diagnostics in India at Inkani Wellness.

The MycoTOX Profile is Mosaic Diagnostics’ most comprehensive assessment of mycotoxins. Our state-of-the-art urine-based assay accurately assesses levels of 11 different mycotoxins, including Aflatoxin M1, Ochratoxin A, Zearalenone, and Trichothecenes. The MycoTOX Profile has been designed to help clinicians uncover mycotoxin exposure and guide a therapeutic strategy for prevention and treatment.

The MycoTOX Profile urine-based assay assesses levels of 11 different mycotoxins.

Aflatoxins: AFM1
Ochratoxin A
Trichothecenes: Roridin E (ROE), Verrucarin A (VRA),
Zearalenone
Chaetoglobosin (CHA)
Enniatin B (ENB)
Gliotoxin (GTX)
Mycophenolic Acid (MPA)
Sterigmatocystin (STC)
Citrinin (CTN)

What Patients Might Benefit
Exposure to molds can negatively impact health either directly through inhalation or dermal contact with mold or mold spores – or indirectly due to the concomitant presence of their secondary metabolites, mycotoxins. Symptoms and disease states associated with mycotoxin exposure include the following:

Alzheimer’s
Anxiety/Depression
Asthma
Autism Spectrum
Bronchitis
Cancer (e.g., Hepatic, Esophageal)
Chronic Fatigue
Cognitive Impairments
Headaches
Infertility
Inflammatory Bowel Disease
Intestinal Permeability
Multiple Sclerosis
Other Mood Impairments
Parkinson’s Disease

Specimen Requirement
10 mL urine minimum

Please see collection instructions for detailed instructions.

Unmask the Growing Health Threat of Mycotoxins
Mycotoxins, produced by certain mold species, are some of the most prevalent toxins and can come from many sources, including buildings, vehicles, and food. These compounds have been recognized as a growing global health concern due to their acute and chronic adverse health impacts. Mycotoxin exposure can be challenging to diagnose without proper testing due to vague and often varied symptoms.

NOTE: MOSAICDX Terms and Conditions.